Silica cages could keep vaccines intact without need for 'cold chain'
Ensilication enables protein-based substances to withstand heat of up to 100ºC and still function as normal.
Biological substances based on proteins, such as vaccines, typically degrade at room temperature over time as the proteins unfold and denature. Storage and distribution therefore relies on a continuous network of refrigeration called the “cold chain”. This process is costly and loss of vaccines through breaks in the chain has a significant impact on global public health.
For the first time, researchers have demonstrated that proteins in solution can be temporarily encased in a tiny silica network, or cage, and subsequently released back into solution, intact and functional.
They found that when a protein in solution is mixed with silica, it surrounds the protein, quickly building up many layers to encase the protein. The “ensilicated” protein can withstand heat of 100 degrees celcius and, once the silica coating is removed, the protein functions as normal.
Publishing their findings in Scientific Reports (online, 24 April 2017), the researchers conclude that the technique could transform vaccine availability worldwide by eliminating the cold chain.
Citation: Clinical Pharmacist DOI: 10.1211/CP.2017.20202715
Recommended from Pharmaceutical Press
Pharmaceutical Press is the publishing division of the Royal Pharmaceutical Society, and is a leading provider of authoritative pharmaceutical information used throughout the world.Visit rpharms.com